Lead, R&D Strategy, Venus Medicine Research Centre, India

Anmol is responsible for advancing VMRC’s pipeline from the inception phase through to market launch. He is involved from bench-to-bedside in the designing and implementation of scientific and business strategy for drug candidates, primarily in the anti-infective segment. He is passionate about Antimicrobial Resistance and is a member of AMR Industry Alliance’s Research and Appropriate Use Working groups.  Anmol is also a part of the founding team at the Preserving Life of Existing Antibiotics (PLEA) Trust and is actively involved in organising various campaigns to increase AMR awareness and promote antibiotic stewardship.